199 related articles for article (PubMed ID: 26575790)
1. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
Oncotarget; 2016 Jan; 7(1):509-23. PubMed ID: 26575790
[TBL] [Abstract][Full Text] [Related]
2. 4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.
Yang Q; Zhu M; Wang Z; Li H; Zhou W; Xiao X; Zhang B; Hu W; Liu J
Tumour Biol; 2016 Sep; 37(9):12713-12723. PubMed ID: 27448302
[TBL] [Abstract][Full Text] [Related]
3. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway.
Bai Y; Liu X; Qi X; Liu X; Peng F; Li H; Fu H; Pei S; Chen L; Chi X; Zhang L; Zhu X; Song Y; Wang Y; Meng S; Jiang T; Shao S
EBioMedicine; 2019 Apr; 42():311-325. PubMed ID: 30922965
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway.
Lu L; Liu Q; Wang P; Wu Y; Liu X; Weng C; Fang X; Li B; Cao X; Mao H; Wang L; Guan M; Wang W; Liu G
BMC Cancer; 2019 Mar; 19(1):209. PubMed ID: 30849960
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14).
Wang R; Wang ZX; Yang JS; Pan X; De W; Chen LB
Oncogene; 2011 Jun; 30(23):2644-58. PubMed ID: 21358675
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics.
Xie D; Wu X; Lan L; Shangguan F; Lin X; Chen F; Xu S; Zhang Y; Chen Z; Huang K; Wang R; Wang L; Song X; Liu Y; Lu B
Oncotarget; 2016 Mar; 7(10):11609-24. PubMed ID: 26820294
[TBL] [Abstract][Full Text] [Related]
7. ROCK1 knockdown inhibits non-small-cell lung cancer progression by activating the LATS2-JNK signaling pathway.
Xin T; Lv W; Liu D; Jing Y; Hu F
Aging (Albany NY); 2020 Jun; 12(12):12160-12174. PubMed ID: 32554853
[TBL] [Abstract][Full Text] [Related]
8. Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
Zhang X; Cai L; Zhou H; Liu Y; Fan C; Wang L; Li A; Miao Y; Li Q; Qiu X; Wang E
Mol Carcinog; 2017 Dec; 56(12):2558-2565. PubMed ID: 28667800
[TBL] [Abstract][Full Text] [Related]
9. GCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotion.
Chen KY; Chen CC; Tseng YL; Chang YC; Chang MC
Oncotarget; 2014 Jul; 5(13):5017-28. PubMed ID: 24970809
[TBL] [Abstract][Full Text] [Related]
10. C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer.
Shi Y; Chen J; Li Z; Zhang Z; Yu H; Sun K; Wang X; Song X; Wang Y; Zhen Y; Yang T; Lou K; Zhang Y; Zhang G; Hu Y; Ji J; Hui R
Oncogene; 2011 Sep; 30(39):4107-17. PubMed ID: 21499297
[TBL] [Abstract][Full Text] [Related]
11. LINC00958 Accelerates Cell Proliferation and Migration in Non-Small Cell Lung Cancer Through JNK/c-JUN Signaling.
Luo Z; Han Z; Shou F; Li Y; Chen Y
Hum Gene Ther Methods; 2019 Dec; 30(6):226-234. PubMed ID: 31855084
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of membrane skeleton protein 4.1 family in non-small cell lung cancer].
Zheng XY; Qi YM; Gao YF; Wang XY; Qi MX; Shi XF; An XL
Ai Zheng; 2009 Jul; 28(7):679-84. PubMed ID: 19624891
[TBL] [Abstract][Full Text] [Related]
13. JNK signaling mediates EPHA2-dependent tumor cell proliferation, motility, and cancer stem cell-like properties in non-small cell lung cancer.
Song W; Ma Y; Wang J; Brantley-Sieders D; Chen J
Cancer Res; 2014 May; 74(9):2444-54. PubMed ID: 24607842
[TBL] [Abstract][Full Text] [Related]
14. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
15. TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway.
Wang SY; Gao K; Deng DL; Cai JJ; Xiao ZY; He LQ; Jiao HL; Ye YP; Yang RW; Li TT; Liang L; Liao WT; Ding YQ
Oncotarget; 2016 Jan; 7(3):2878-88. PubMed ID: 26701208
[TBL] [Abstract][Full Text] [Related]
16. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
17. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
[TBL] [Abstract][Full Text] [Related]
18. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
Vicent S; Garayoa M; López-Picazo JM; Lozano MD; Toledo G; Thunnissen FB; Manzano RG; Montuenga LM
Clin Cancer Res; 2004 Jun; 10(11):3639-49. PubMed ID: 15173070
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer.
Ming J; Jiang G; Zhang Q; Qiu X; Wang E
Cancer Immunol Immunother; 2012 Jan; 61(1):79-88. PubMed ID: 21847632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]